FIELD: medicine.
SUBSTANCE: invention relates to a method for the treatment of a patient with a periodic explosive disorder, including the administration to the specified patient of a compound of the formula
or pharmaceutically acceptable salt of any of the specified compounds.
EFFECT: compounds are proposed for the effective treatment of a periodic explosive disorder.
5 cl, 2 dwg, 238 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS OF TREATING NEURODEGENERATIVE DISEASES | 2015 |
|
RU2742773C2 |
METHOD FOR PTSD TREATMENT | 2011 |
|
RU2623209C9 |
COMPOSITIONS AND METHODS FOR TREATMENT OF BRAIN DAMAGE | 2018 |
|
RU2797548C2 |
PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
5-AMINOCYCLYLMETHYLOXAZOLIDIN-2-ONE DERIVATIVES | 2008 |
|
RU2492169C2 |
SPIROCYCLIC CYCLOHEXANE DERIVATIVES | 2008 |
|
RU2470933C2 |
COMPOUNDS OF THIENOPYRIMIDINE | 2013 |
|
RU2637925C2 |
TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
METHOD FOR PRODUCTION OF HYDROXYLATED CYCLOPENTYL PYRIMIDINE COMPOUNDS | 2013 |
|
RU2643811C2 |
Authors
Dates
2022-07-11—Published
2011-07-01—Filed